Sinopharm Group Co. Ltd. (HKG:1099)
19.22
-0.34 (-1.74%)
Apr 24, 2026, 4:08 PM HKT
Sinopharm Group Revenue
Sinopharm Group had revenue of 17.82B CNY in the quarter ending March 31, 2026, a decrease of -87.42%. This brings the company's revenue in the last twelve months to 574.70B, down -0.73% year-over-year. In the year 2025, Sinopharm Group had annual revenue of 575.17B, down -1.60%.
Revenue (ttm)
574.70B CNY
Revenue Growth
-0.73%
P/S Ratio
0.09
Revenue / Employee
6.06M CNY
Employees
94,910
Market Cap
59.98B HKD
Revenue Chart
* This company reports financials in CNY.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 575.17B | -9.34B | -1.60% |
| Dec 31, 2024 | 584.51B | -12.06B | -2.02% |
| Dec 31, 2023 | 596.57B | 44.42B | 8.05% |
| Dec 31, 2022 | 552.15B | 31.10B | 5.97% |
| Dec 31, 2021 | 521.05B | 64.64B | 14.16% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Charmacy Pharmaceutical | 4.88B |
| ETHK Labs | 3.14B |
| Sinco Pharmaceuticals Holdings | 2.32B |
| Sipai Health Technology | 2.30B |
| ClouDr Group | 1.81B |
| 160 Health International | 725.41M |
| Ziyuanyuan Holdings Group | 535.97M |
| Wanjia Group Holdings | 163.70M |